Discovery of novel pyrrole derivatives as potent agonists for the niacin receptor GPR109A

Bioorg Med Chem Lett. 2020 May 15;30(10):127105. doi: 10.1016/j.bmcl.2020.127105. Epub 2020 Mar 10.

Abstract

Novel pyrrole derivatives were discovered as potent agonists of the niacin receptor, GPR109A. During the derivatization, compound 16 was found to be effective both in vitro and in vivo. The compound 16 exhibited a significant reduction of the non-esterified fatty acid in human GPR109A transgenic rats, and the duration of its in vivo efficacy was much longer than niacin.

Keywords: GPR109A; Lipolysis; Niacin; Non-esterified fatty acid; Pyrrole.

MeSH terms

  • Animals
  • Drug Design
  • Fatty Acids, Nonesterified / metabolism
  • Humans
  • Lipolysis / drug effects
  • Nicotinic Agonists / chemistry*
  • Nicotinic Agonists / metabolism
  • Nicotinic Agonists / pharmacology
  • Pyrroles / chemistry*
  • Pyrroles / metabolism
  • Pyrroles / pharmacology
  • Rats
  • Rats, Transgenic
  • Receptors, G-Protein-Coupled / agonists*
  • Receptors, G-Protein-Coupled / metabolism
  • Structure-Activity Relationship

Substances

  • Fatty Acids, Nonesterified
  • HCAR2 protein, human
  • Nicotinic Agonists
  • Pyrroles
  • Receptors, G-Protein-Coupled